PMID- 19542300 OWN - NLM STAT- MEDLINE DCOM- 20090930 LR - 20240508 IS - 1528-0020 (Electronic) IS - 0006-4971 (Print) IS - 0006-4971 (Linking) VI - 114 IP - 8 DP - 2009 Aug 20 TI - Minor viral and host genetic polymorphisms can dramatically impact the biologic outcome of an epitope-specific CD8 T-cell response. PG - 1553-62 LID - 10.1182/blood-2009-02-206193 [doi] AB - Human immunodeficiency virus-1 subtypes A and C differ in the highly conserved Gag-TL9 epitope at a single amino acid position. Similarly, the TL9 presenting human leukocyte antigen (HLA) class I molecules B42 and B81 differ only at 6 amino acid positions. Here, we addressed the influence of such minor viral and host genetic variation on the TL9-specific CD8 T-cell response. The clonotypic characteristics of CD8 T-cell populations elicited by subtype A or subtype C were distinct, and these responses differed substantially with respect to the recognition and selection of TL9 variants. Irrespective of the presenting HLA class I molecule, CD8 T-cell responses elicited by subtype C exhibited largely comparable TL9 variant cross-recognition properties, expressed T-cell receptors that used almost exclusively the TRBV 12-3 gene, and selected for predictable patterns of viral variation within TL9. In contrast, subtype A elicited TL9-specific CD8 T-cell populations with completely different, more diverse TCRBV genes and did not select for viral variants. Moreover, TL9 variant cross-recognition properties were extensive in B81(+) subjects but limited in B42(+) subjects. Thus, minor viral and host genetic polymorphisms can dramatically alter the immunologic and virologic outcome of an epitope-specific CD8 T-cell response. FAU - Geldmacher, Christof AU - Geldmacher C AD - Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA. geldmacher@lrz.uni-muenchen.de FAU - Metzler, Ian S AU - Metzler IS FAU - Tovanabutra, Sodsai AU - Tovanabutra S FAU - Asher, Tedi E AU - Asher TE FAU - Gostick, Emma AU - Gostick E FAU - Ambrozak, David R AU - Ambrozak DR FAU - Petrovas, Constantinos AU - Petrovas C FAU - Schuetz, Alexandra AU - Schuetz A FAU - Ngwenyama, Njabulo AU - Ngwenyama N FAU - Kijak, Gustavo AU - Kijak G FAU - Maboko, Leonard AU - Maboko L FAU - Hoelscher, Michael AU - Hoelscher M FAU - McCutchan, Francine AU - McCutchan F FAU - Price, David A AU - Price DA FAU - Douek, Daniel C AU - Douek DC FAU - Koup, Richard A AU - Koup RA LA - eng GR - ImNIH/Intramural NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Intramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20090619 PL - United States TA - Blood JT - Blood JID - 7603509 RN - 0 (DNA, Viral) RN - 0 (Epitopes, T-Lymphocyte) RN - 0 (Histocompatibility Antigens Class I) RN - 0 (Receptors, Antigen, T-Cell) RN - 0 (Viral Proteins) SB - IM MH - Amino Acid Sequence MH - CD8-Positive T-Lymphocytes/*immunology/metabolism MH - DNA Mutational Analysis MH - DNA, Viral/analysis/genetics MH - Epitopes, T-Lymphocyte/*genetics/immunology MH - Female MH - HIV Infections/genetics/immunology MH - HIV-1/*genetics/*immunology MH - Histocompatibility Antigens Class I/*genetics MH - Host-Pathogen Interactions/genetics/immunology MH - Humans MH - Polymorphism, Genetic/*physiology MH - Receptors, Antigen, T-Cell/genetics MH - Sequence Homology, Amino Acid MH - T-Cell Antigen Receptor Specificity/genetics/immunology MH - Viral Proteins/genetics/immunology PMC - PMC2731637 EDAT- 2009/06/23 09:00 MHDA- 2009/10/01 06:00 PMCR- 2010/08/20 CRDT- 2009/06/23 09:00 PHST- 2009/06/23 09:00 [entrez] PHST- 2009/06/23 09:00 [pubmed] PHST- 2009/10/01 06:00 [medline] PHST- 2010/08/20 00:00 [pmc-release] AID - S0006-4971(20)37181-0 [pii] AID - 2009/206193 [pii] AID - 10.1182/blood-2009-02-206193 [doi] PST - ppublish SO - Blood. 2009 Aug 20;114(8):1553-62. doi: 10.1182/blood-2009-02-206193. Epub 2009 Jun 19.